Skip navigation

Prof. Dr. med. Hans-Dieter Volk

Hans-Dieter Volk has been director of the BCRT since its establishment in 2006. In addition, he is head of the Institute of Medical Immunology at the Charité - Universitätsmedizin Berlin since 1994, and the Department of Immunology of the Labor Berlin-Charité Vivantes GmbH since 2011. Taking a translational approach, Hans-Dieter Volk combines basic and clinical research in immunology. This has allowed him and his team to develop new diagnostic products and therapies for immune diseases, which are already on the market. His research work focuses on the development of biomarkers, transplantation immunology, the immunopathogenesis of virus infections of the herpes group of viruses, and the role of inhibitory cytokines and regulatory T cells. Hans-Dieter Volk works closely with other research groups at Charité and the BCRT as well as a number of biotech and pharma companies and the Charité Research Organization GmbH to translate his research findings into clinical applications as quickly as possible. The institute has spawned a number of successful biotech spin-off companies including Jerini AG, ProBioGen AG, T Cell Europe GmbH and Cellserve GmbH.


  • 1974-80: Study of Medicine at the Charité, Humboldt University Berlin
  • 1980: Diploma Thesis in transplantation immunology
  • 1980: Licensed to practice medicine
  • 1980-82: Doctor of Medicine at the Charité, Humboldt University Berlin (summa cum laude)
  • 1987: Postdoctoral teaching qualification in Immunology at the Charité

Professional History

  • 1980-86: Resident physician and research associate at the Institute of Medical Immunology, Charité, Humboldt University Berlin
  • 1982-84: Various visiting fellowships (9 months in total) at the Institutes of Immunology at the Universities of Leipzig, Jena and Rostock
  • 1984: Specialization in clinical immunology
  • 1986-93: Senior physician and head of the Department of Clinical Immunology, Charité, Humboldt University Berlin
  • 1987: Visiting fellow at the University of Innsbrück, Department of Hematology (Prof. Ch. Huber)
  • 1987: Appointed university lecturer at the Humboldt University Berlin/Charité
  • 1989-90: One-year fellowship at the Institute of Immunology, Freie Universität Berlin (Prof. Diamantstein)
  • 1993-94: Acting head of the Institute of Medical Immunology, Charité, Humboldt University Berlin
  • 1994: Appointed C3 Professor of Immunology
  • 1994: Director of the Institute of Medical Immunology, Charité, Humboldt University Berlin
  • 1994: Appointed C3 Professor at the University of Heidelberg (surrendered)
  • 2001: Appointed Full Professor of Clinical Immunology, University of Minnesota (surrendered)

Awards & Honors

  • 1988: Rudolf Virchow Research Award
  • 1983: Humboldt Research Award
  • Member of the Scientific Advisory Boards of Cardion AG and GenPat 77 AG
  • Member of the Supervisory Board of Probiogen AG
  • Scientific advisor to Bayer-Schering AG, Baxter AG, Parexel GmbH, Altana AG, Becton-Dickinson Inc., Diagnostic Products Corporation Inc.
  • Member of Leibniz Society of Sciences e.V.

Memberships & Editorships

  • International Society of Transplantation
  • German Society of Immunology (Board Member)
  • German Society of Transplantation
  • American Society of Transplantation (Member of the Committees: Infectious Diseases, Basic Science)
  • Scientific Advisory Board of the Immune Tolerance Network of the NIH, Bethesda, USA
  • Member of the Editorial Board of Transplantation
  • Associate Editor American Journal of Transplantation